To cite this paper use one of the standards below:
Inter-individual variability (IIV) of flavan-3-ol metabolites production may be a limiting factor in their association with health effects. This variability is affected by personal differences, genetic background, and gut microbiota composition, resulting in different metabotypes. The aim was to verify the replication of flavan-3-ol metabotypes after an oral (poly)phenol challenge test (OPCT) and to understand their formation. Volunteers (n=287) were submitted to an OPCT, a 3 tablets challenge containing a profile and level of (poly)phenols mimicking European dietary habits, and spot urine samples were collected after 24 h. Urine samples were analyzed by LC-IMS-qToF-HRMS for flavan-3-ol metabolite identification. The response of each metabolite was normalized to creatine excretion and a multivariate statistic was applied to cluster individuals by flavan-3-ol excretion profiles. A total of 63 phase II metabolites were identified, 5 of which were epicatechin derivatives and 58 microbiota catabolites such as phenyl-γ-valerolactones (PVLs) and phenylvaleric acids (PVAs). A 3 components principal component analysis revealed a clustering of volunteers into two major groups distinguished by high excretors of trihydroxy-PVLs/PVAs and high excretors of monohydroxy-PVLs/PVAs with explained variation of 70% (R2(X) = 0.70) and predictive ability of 46% (Q2 = 0.46). The phase II metabolites of 3ʹ,4ʹ-dihydroxy-PVL, the most abundantly excreted, do not contribute to the clustering, however 3ʹ,5ʹ-dihydroxy-PVL/PVA metabolites can be used to classify subjects. This data confirmed previous preliminary results with a large set of volunteers and shed light on the differences in metabolic phenotypes. Further research is ongoing to fully unravel the factors driving the differences observed, as genetic determinants or gut microbiota composition.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper